Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12618000167268
ACTRN12618000167268
Completed
Phase 1

Contrast-induced nephropathy in chronic kidney disease patients undergoing angiography and treatment with combined induced diuresis and euvolemic fluid resuscitation: a randomised controlled trial.

A/Prof Margaret Arstall0 sites166 target enrollmentFebruary 2, 2018
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsContrast-induced nephropathyChronic kidney diseaseRenal and Urogenital - Kidney disease

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Contrast-induced nephropathy
Sponsor
A/Prof Margaret Arstall
Enrollment
166
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 2, 2018
End Date
September 20, 2022
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
A/Prof Margaret Arstall

Eligibility Criteria

Inclusion Criteria

  • •Inclusion criteria for this trial include:
  • •1\. All adult patients with advanced stage III, IV or V chronic kidney disease (serum creatinine more than 1\.6 mg/dl (145 mmol/L) and eGFR of less than 40ml/min/1\.73m2, and/or Mehran's risk score of 6\-16\) undergoing an elective or urgent, diagnostic or therapeutic radiocontrast procedure will be approached for consent.

Exclusion Criteria

  • •Exclusion criteria for this trial include:
  • •1\. Patients with contrast allergy
  • •2\. Hypersensitivity to furosemide
  • •3\. Patient on maintenance haemodialysis or peritoneal dialysis
  • •4\. Radiocontrast procedure conducted within 72 hours
  • •5\. Contraindication or failure to pass urinary catheter
  • •6\. Patients with fluctuating baseline serum creatinine measurements
  • •7\. Patients with acute renal failure
  • •8\. Patients requiring emergency angiography procedures (e.g. STEMI cases)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Unknown
N/A
Acute kidney injury in patients treated for symptomatic peripheral arterial diseasePAD:Peripheral artery diseaseCRI:Chronic renal insufficiencyIC:Intermittent claudicationCLI:Critical limb ischemiaGFR: Glomerular filtration ratePTA:Percutaneous transluminal angioplastyCIN:Contrast induced nephropathyPCI:Percutaneous coronary interventionCKD:Chronic kidney disease
NL-OMON26709T.A. Sigterman MD, Resident general surgeryDepartment of SurgeryAtrium Medical CentreHenri Dunantstraat 56419PC Heerlen Email: timsigterman@gmail.com350
Not Yet Recruiting
N/A
Renal dysfunction in patients undergoing primary PCI for acute myocardial infraction.
CTRI/2018/06/014495Kasturba medical college and hospital
Recruiting
N/A
Incidence of contrast induced nephropathy,comparison of sodium chloride and sodium bicarbonate
JPRN-UMIN000006896Kagawa Medical School Hospital200
Recruiting
N/A
Contrast-induced renal disease in renal patients
RBR-3h2gv8rHospital Geral de Goiania dr Alberto Rassi
Active, Not Recruiting
N/A
Contrast indiced nephropaty (CIN) in patients undergoing primary angioplasty for acute myocardial infarction. Randomized trial on the effects of hydration with saline or sodium bicarbonate. - NDAMIMedDRA version: 6.1Level: SOCClassification code 10007541
EUCTR2007-002149-20-ITAZIENDA OSPEDALIERA ARCISPEDALE S. MARIA NUOVA